Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 3Peripheral Nervous System Diseases 2Mucositis 2Head and Neck Neoplasms 2Vaso-Occlusive Crises 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Pain 1Gastrointestinal Neoplasms 1Esophagitis 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Anemia, Sickle Cell 1

Interventions

Bevacizumab 5Leucovorin 4Irinotecan 4Fluorouracil 4Oxaliplatin 3Capecitabine 3Drug Therapy 2trifluridine tipiracil drug combination 1romiplostim 1napabucasin 1entecavir 1encorafenib 1durvalumab 1apatinib 1abelacimab 1Sunitinib 1Specimen Handling 1Sodium Chloride 1S-1 plus cisplatin 1Radiosurgery 1Palonosetron 1Oviposition 1Nutrition Assessment 1Nucleotides 1Methylphenidate 1Memantine 1Melatonin 1Magnetic Resonance Spectroscopy 1MAA868 1Levoleucovorin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Gastrointestinal Neoplasms × Glutamine × Clear all
NCT00455247 2013-06-05

Efficacy of an Oral Formula in Prevention of Anti-cancer Therapy Side Effects

Société des Produits Nestlé (SPN)

Phase 3 Completed
Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡